Which medicines could be in short supply in 2022? The pandemic has proven time and time again that it is a potent driver of shortages – but the end of COVID-induced medicine supply issues may come sooner than expected.
Taking the burden out of anticholinergic medicines A new program targeting the use of anticholinergic medicines has been launched by NPS MedicineWise.
What medicines are prescribed the most in Australia? While statin medications take the lion’s share, antidepressants are being prescribed more, and antibiotics less.
National Medicines Policy submission focuses on clinical practice Key recommendations for the policy’s review put forward by the RACGP are aimed at ensuring access, safety and quality.
In Practice: What are the latest college submissions? GPs and GPs in training can also learn more about current rural health topics and apply for educational committees.
Further room for improvement in health literacy Recent patient feedback further establishes GPs’ stewardship role in health literacy and safeguarding quality use of medicines.
Helping people in CALD communities understand active ingredients New resources have been developed to help people in culturally and linguistically diverse communities better understand their medications.
PBS to provide access to life-saving MS and cancer medicines New medicines for multiple sclerosis and various cancers will be available on the Pharmaceutical Benefits Scheme from 1 November.
High-risk sports supplements to be regulated as medicines The TGA will regulate supplements formulated to look like medicines with therapeutic claims from 30 November.
Pharmaceutical Benefits Advisory Council responds to criticism Chair Andrew Wilson said suggestions of delayed approvals are not new and Australia has one of ‘the fastest systems in the world’.